These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 20406305)

  • 1. Peroxisome proliferator-activated receptor delta agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis.
    Kanakasabai S; Chearwae W; Walline CC; Iams W; Adams SM; Bright JJ
    Immunology; 2010 Aug; 130(4):572-88. PubMed ID: 20406305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PPARδ deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis.
    Kanakasabai S; Walline CC; Chakraborty S; Bright JJ
    Brain Res; 2011 Feb; 1376():101-12. PubMed ID: 21192919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity.
    Dunn SE; Bhat R; Straus DS; Sobel RA; Axtell R; Johnson A; Nguyen K; Mukundan L; Moshkova M; Dugas JC; Chawla A; Steinman L
    J Exp Med; 2010 Aug; 207(8):1599-608. PubMed ID: 20624891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation.
    Natarajan C; Bright JJ
    Genes Immun; 2002 Apr; 3(2):59-70. PubMed ID: 11960303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma-deficient heterozygous mice develop an exacerbated neural antigen-induced Th1 response and experimental allergic encephalomyelitis.
    Natarajan C; Muthian G; Barak Y; Evans RM; Bright JJ
    J Immunol; 2003 Dec; 171(11):5743-50. PubMed ID: 14634082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2.
    Raikwar HP; Muthian G; Rajasingh J; Johnson CN; Bright JJ
    J Neuroimmunol; 2006 Sep; 178(1-2):76-86. PubMed ID: 16844232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
    Rostami A; Ciric B
    J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin Suppresses T Helper 17 Cell Differentiation and Limits Autoimmune CNS Inflammation via the SIRT1/PPARγ/RORγt Pathway.
    Zhang K; Guo Y; Ge Z; Zhang Z; Da Y; Li W; Zhang Z; Xue Z; Li Y; Ren Y; Jia L; Chan KH; Yang F; Yan J; Yao Z; Xu A; Zhang R
    Mol Neurobiol; 2017 Sep; 54(7):4908-4920. PubMed ID: 27514756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPARgamma antagonists exacerbate neural antigen-specific Th1 response and experimental allergic encephalomyelitis.
    Raikwar HP; Muthian G; Rajasingh J; Johnson C; Bright JJ
    J Neuroimmunol; 2005 Oct; 167(1-2):99-107. PubMed ID: 16091293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis.
    Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z
    J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.
    Serada S; Fujimoto M; Mihara M; Koike N; Ohsugi Y; Nomura S; Yoshida H; Nishikawa T; Terabe F; Ohkawara T; Takahashi T; Ripley B; Kimura A; Kishimoto T; Naka T
    Proc Natl Acad Sci U S A; 2008 Jul; 105(26):9041-6. PubMed ID: 18577591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
    Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
    J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
    Murphy AC; Lalor SJ; Lynch MA; Mills KH
    Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome Proliferator-Activated Receptor-δ Acts within Peripheral Myeloid Cells to Limit Th Cell Priming during Experimental Autoimmune Encephalomyelitis.
    Drohomyrecky PC; Doroshenko ER; Akkermann R; Moshkova M; Yi TJ; Zhao FL; Ahn JJ; McGaha TL; Pahan K; Dunn SE
    J Immunol; 2019 Nov; 203(10):2588-2601. PubMed ID: 31578267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
    Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
    Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
    Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
    J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Fletcher JM; Lalor SJ; Sweeney CM; Tubridy N; Mills KH
    Clin Exp Immunol; 2010 Oct; 162(1):1-11. PubMed ID: 20682002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 plays a critical role in the development of experimental autoimmune encephalomyelitis by mediating Th1 and Th17 responses.
    Gris D; Ye Z; Iocca HA; Wen H; Craven RR; Gris P; Huang M; Schneider M; Miller SD; Ting JP
    J Immunol; 2010 Jul; 185(2):974-81. PubMed ID: 20574004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
    Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN
    PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.